Navigation Links
NeoGenomics to Present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference
Date:2/11/2009

FT. MYERS, Fla., Feb. 11 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference in Dana Point, California. The date, time and location of the Company's presentation at the conference are as follows:

        Date:          Monday, February 16, 2009
        Time:          4:20 PM Pacific Time
        Venue:         The Ritz Carlton Laguna Niguel
                       One Ritz-Carlton Drive
                       Dana Point, California 92629

Webcast Link: http://www.wsw.com/webcast/roth20/ngnm/

The Roth 21st Annual OC Growth Stock Conference will feature presentations from over 200 growth companies. This event is designed to provide investors with a unique opportunity to gain insight into leading companies across all sectors. Additionally, there will be a special track dedicated to microcap companies. A live audio webcast of the presentation can be accessed at http://www.wsw.com/webcast/roth20/ngnm/. A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at http://www.neogenomics.org at the time of the conference. The webcast will be available for three months. Interested parties and investors may also find more information about the conference by contacting conference@roth.com or calling (800) 933-6830.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.

Interested parties can also access additional investor relations material from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates at http://www.hawkassociates.com. An investment profile about NeoGenomics may be found at www.hawkassociates.com/profile/ngnm.cfm .

About Roth

Roth is a full service investment banking firm dedicated to the small and micro-cap market. Since the inception of the firm in 1984, Roth has been a leader and innovator in the small and micro cap markets. Roth's exclusive focus has been, is, and will continue to offer a full spectrum of investment banking services, including raising capital, research coverage, trading and market making, merger and acquisition advisory services, and investor conferences.


'/>"/>
SOURCE NeoGenomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
2. NeoGenomics to Present at the Noble Financial Equity Conference
3. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
4. NeoGenomics Announces Results for the 3rd Quarter 2007
5. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
6. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
7. Penn Medicine presents HIV gene therapy trial data at CROI 2009
8. NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference
9. VNUS Medical Technologies to Present at the Roth 21st Annual OC Growth Stock Conference
10. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
11. Covance to Present at the 2009 UBS Global Healthcare Services Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Peter ... the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to Texas as a part of its national Swirl: A Wine Tasting Event ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American College of ... its recently formed Corporate Roundtable, a group of individuals and organizations whose collective ... , Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings and ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of Multiple ... for the discomforts and hidden dangers of foot fungus, particularly in the warm ... risk for developing fungal infections on the feet or toenails, the Board says. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Leonard I. Linkow, DDS, DMSC, sets a new ... Xlibris on July of 2014). This book details the recent advances and techniques in ... benefit people who have lost all of their natural teeth . , In ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 ... D.C. offering free MRI brain scans to the public.Where:  ... be parked at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: